Drug intelligence / Profile preview

Topisal-MF

Development stage
Unknown
Lead developer
Systopic Laboratories
Modality
Small Molecules
Administration
Topical
01

Overview

Topisal-MF is a topical combination ointment developed by Systopic Laboratories for the treatment of severe, dry, and scaly dermatological conditions, such as psoriasis, eczema, and contact dermatitis. It is formulated with a synergistic blend of active ingredients: clobetasol propionate, salicylic acid, lactic acid, sodium lactate, and urea. Clobetasol propionate is a superpotent topical corticosteroid that binds to the glucocorticoid receptor to suppress inflammatory pathways, reducing redness, swelling, and itching. Salicylic acid, lactic acid, and urea act as keratolytic agents and humectants that break down keratin clumps, promote the desquamation of dead skin cells, and deeply hydrate the skin. This keratolytic action also enhances the penetration and efficacy of clobetasol propionate into the deeper epidermal layers.

Brand names
Topisal-MFTopisal-MF 3% OintmentTopisal-MF 6% Ointment
Other names
Topisal-MF 3/6 Ointment
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Topisal-MF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Topisal-MF.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call